Solventum Corporation (SOLV)
NYSE: SOLV · Real-Time Price · USD
85.43
+0.17 (0.20%)
Dec 5, 2025, 4:00 PM EST - Market closed
Solventum Revenue
Solventum had revenue of $2.10B in the quarter ending September 30, 2025, with 0.67% growth. This brings the company's revenue in the last twelve months to $8.40B, up 2.28% year-over-year. In the year 2024, Solventum had annual revenue of $8.25B with 0.70% growth.
Revenue (ttm)
$8.40B
Revenue Growth
+2.28%
P/S Ratio
1.77
Revenue / Employee
$381,909
Employees
22,000
Market Cap
14.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.25B | 57.00M | 0.70% |
| Dec 31, 2023 | 8.20B | 67.00M | 0.82% |
| Dec 31, 2022 | 8.13B | -41.00M | -0.50% |
| Dec 31, 2021 | 8.17B | 890.00M | 12.22% |
| Dec 31, 2020 | 7.28B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SOLV News
- 1 day ago - These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them? - The Motley Fool
- 3 days ago - Solventum Corporation (SOLV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 10 days ago - Solventum to Participate in the 2025 Piper Sandler Healthcare Conference - PRNewsWire
- 15 days ago - Solventum Announces $1 Billion Share Repurchase Program - PRNewsWire
- 15 days ago - Solventum Announces Agreement to Acquire Acera Surgical - PRNewsWire
- 23 days ago - Solventum Corporation (SOLV) Presents at Stifel 2025 Healthcare Conference Transcript - Seeking Alpha
- 24 days ago - Solventum: A Mixed Q3 Provides Further Support For Our Neutral Stance - Seeking Alpha
- 4 weeks ago - Solventum Corporation (SOLV) Q3 2025 Earnings Call Transcript - Seeking Alpha